Status:
RECRUITING
Nutritional Support During Induction Therapy for Esophageal Cancer
Lead Sponsor:
Mehdi Qiabi
Conditions:
Esophageal Cancer
Nutrition Aspect of Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Patients diagnosed with esophageal cancer have difficulty eating, as the food pipe becomes obstructed by the cancer. This may impair the ability for the patient to receive appropriate calorie intake, ...
Detailed Description
Esophageal cancer is highly lethal. In Ontario in 2020, an estimated 900 patients were diagnosed with esophageal cancer, while 860 died from it. In Canada, the figures are 2400 diagnoses and 2260 deat...
Eligibility Criteria
Inclusion
- Adult patient
- Non-cervical biopsy-proven esophageal or gastroesophageal junction (Siewert I or II) cancer
- Patient eligible for induction therapy then esophagectomy (stage Ib to III)
Exclusion
- Impossibility to pass an endoscope beyond the tumour
- metastatic disease
- early-stage disease with either upfront esophagectomy or endoscopic resection planned
- patient refusal of the feeding tube
- inability to swallow their pill
- inability to tolerate a full fluid diet
Key Trial Info
Start Date :
November 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2024
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT05314946
Start Date
November 1 2022
End Date
December 31 2024
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre - Victoria Hospital
London, Ontario, Canada, N6A 5W9